相关实验视频
Updated: Jul 16, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
500
当前减肥药物:整形外科医生应该知道的东西
Aesthetic surgery journal
|September 14, 2023
概括
抗糖尿病药物越来越多地用于减肥. 整形外科医生必须了解它们对寻求美容手术和体重控制的患者的好处和风险.
科学领域:
- 药理学和内分泌学 药理学和内分泌学
- 整形外科和美容医学 整形外科和美容医学
背景情况:
- 全球肥胖流行:根据世界卫生组织 (WHO) 的数据,全球超过6.5亿成年人患有肥胖症.
- 新兴趋势:抗糖尿病药物作为有效的减肥治疗方法越来越受欢迎.
- 临床相关性:患者使用量增加需要了解整形手术实践和医疗温泉.
研究的目的:
- 探索抗糖尿病药物对整形外科患者减肥的潜在益处.
- 概述这些药物使用时的关键安全考虑和协同效应.
- 为将这些药物纳入美学和体重管理方案提供指导.
主要方法:
- 关于用于减肥的抗糖尿病药物的科学文献的综述.
- 对作用机制,临床疗效和不良事件概况的分析.
- 对整形外科医生和医疗水疗中心从业人员的实际考虑进行讨论.
主要成果:
- 抗糖尿病药物在通过各种机制促进减肥方面表现出显著的有效性.
- 潜在的副作用和禁忌需要对患者进行仔细的选择和监测.
- 与美学程序的协同效应需要进一步的研究和临床意识.
结论:
- 抗糖尿病药物在整形手术候选人中为体重管理提供了有希望的辅助.
- 对药理学,疗效和安全性的彻底理解对于成功的整合至关重要.
- 需要进一步的研究来优化它们在美学医学中的使用和患者的治疗结果.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
203
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
203
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
696
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
696
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
112
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
112
Drugs for Treatment of Constipation-Predominant IBS
201
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
201
Glucagon-like Receptor Agonists
357
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
357

